Lung Rest with Femoro-Femoral Veno-Venous Extracorporeal Membrane Oxygenation for COVID-19 Severe Pneumonia with Pneumomediastinum. 2022

Tomoo Kishaba, and Tomoharu Suzuki, and Shoshin Yamazato, and Tadayoshi Miyagi, and Hiroaki Nagano
Department of Respiratory Medicine, Okinawa Chubu Hospital.

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) sometimes causes severe coronavirus disease 2019 (COVID-19) pneumonia. Here, we report the case of a 35-year-old man with obesity who showed severe respiratory failure from SARS-CoV-2 infection. Immediate high-resolution computed tomography (HRCT) of the chest after endotracheal intubation revealed a significant pneumomediastinum with diffuse ground-glass opacity and consolidation. Ventilator management was difficult with low tidal volume and low positive end expiratory pressure. Therefore, we administered extracorporeal membrane oxygenation (ECMO) to allow lung rest and prevent further progression of the pneumomediastinum and maintain oxygenation. Since implementing ECMO, the patient's oxygenation has stabilized and follow-up HRCT of the chest revealed dramatic improvement of the pneumomediastinum. We gradually tapered off ECMO and employed a pressure-control mode. He was extubated on day 11. To our knowledge, this is the first reported patient who showed complete pneumomediastinum recovery from COVID-19 pneumonia with ECMO.

UI MeSH Term Description Entries
D008168 Lung Either of the pair of organs occupying the cavity of the thorax that effect the aeration of the blood. Lungs
D008297 Male Males
D008478 Mediastinal Emphysema Presence of air in the mediastinal tissues due to leakage of air from the tracheobronchial tree, usually as a result of trauma. Emphysema, Mediastinal,Interstitial Emphysema,Interstitial Emphysema of Lung,Pneumomediastinum,Pulmonary Interstitial Emphysema,Emphysema, Interstitial,Emphysema, Pulmonary Interstitial,Emphysemas, Pulmonary Interstitial,Interstitial Emphysema, Pulmonary,Interstitial Emphysemas, Pulmonary,Lung Interstitial Emphysema,Mediastinal Emphysemas,Pneumomediastinums,Pulmonary Interstitial Emphysemas
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000086382 COVID-19 A viral disorder generally characterized by high FEVER; COUGH; DYSPNEA; CHILLS; PERSISTENT TREMOR; MUSCLE PAIN; HEADACHE; SORE THROAT; a new loss of taste and/or smell (see AGEUSIA and ANOSMIA) and other symptoms of a VIRAL PNEUMONIA. In severe cases, a myriad of coagulopathy associated symptoms often correlating with COVID-19 severity is seen (e.g., BLOOD COAGULATION; THROMBOSIS; ACUTE RESPIRATORY DISTRESS SYNDROME; SEIZURES; HEART ATTACK; STROKE; multiple CEREBRAL INFARCTIONS; KIDNEY FAILURE; catastrophic ANTIPHOSPHOLIPID ANTIBODY SYNDROME and/or DISSEMINATED INTRAVASCULAR COAGULATION). In younger patients, rare inflammatory syndromes are sometimes associated with COVID-19 (e.g., atypical KAWASAKI SYNDROME; TOXIC SHOCK SYNDROME; pediatric multisystem inflammatory disease; and CYTOKINE STORM SYNDROME). A coronavirus, SARS-CoV-2, in the genus BETACORONAVIRUS is the causative agent. 2019 Novel Coronavirus Disease,2019 Novel Coronavirus Infection,2019-nCoV Disease,2019-nCoV Infection,COVID-19 Pandemic,COVID-19 Pandemics,COVID-19 Virus Disease,COVID-19 Virus Infection,Coronavirus Disease 2019,Coronavirus Disease-19,SARS Coronavirus 2 Infection,SARS-CoV-2 Infection,Severe Acute Respiratory Syndrome Coronavirus 2 Infection,COVID19,2019 nCoV Disease,2019 nCoV Infection,2019-nCoV Diseases,2019-nCoV Infections,COVID 19,COVID 19 Pandemic,COVID 19 Virus Disease,COVID 19 Virus Infection,COVID-19 Virus Diseases,COVID-19 Virus Infections,Coronavirus Disease 19,Disease 2019, Coronavirus,Disease, 2019-nCoV,Disease, COVID-19 Virus,Infection, 2019-nCoV,Infection, COVID-19 Virus,Infection, SARS-CoV-2,Pandemic, COVID-19,SARS CoV 2 Infection,SARS-CoV-2 Infections,Virus Disease, COVID-19,Virus Infection, COVID-19
D000086402 SARS-CoV-2 A species of BETACORONAVIRUS causing atypical respiratory disease (COVID-19) in humans. The organism was first identified in 2019 in Wuhan, China. The natural host is the Chinese intermediate horseshoe bat, RHINOLOPHUS affinis. 2019 Novel Coronavirus,COVID-19 Virus,COVID19 Virus,Coronavirus Disease 2019 Virus,SARS Coronavirus 2,SARS-CoV-2 Virus,Severe Acute Respiratory Syndrome Coronavirus 2,Wuhan Coronavirus,Wuhan Seafood Market Pneumonia Virus,2019-nCoV,2019 Novel Coronaviruses,COVID 19 Virus,COVID-19 Viruses,COVID19 Viruses,Coronavirus 2, SARS,Coronavirus, 2019 Novel,Coronavirus, Wuhan,Novel Coronavirus, 2019,SARS CoV 2 Virus,SARS-CoV-2 Viruses,Virus, COVID-19,Virus, COVID19,Virus, SARS-CoV-2,Viruses, COVID19
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D015199 Extracorporeal Membrane Oxygenation Application of a life support system that circulates the blood through an oxygenating system, which may consist of a pump, a membrane oxygenator, and a heat exchanger. Examples of its use are to assist victims of SMOKE INHALATION INJURY; RESPIRATORY FAILURE; and CARDIAC FAILURE. ECMO Extracorporeal Membrane Oxygenation,Oxygenation, Extracorporeal Membrane,Venoarterial ECMO,Venoarterial Extracorporeal Membrane Oxygenation,Venovenous ECMO,Venovenous Extracorporeal Membrane Oxygenation,ECLS Treatment,ECMO Treatment,Extracorporeal Life Support,ECLS Treatments,ECMO Treatments,ECMO, Venoarterial,ECMO, Venovenous,Extracorporeal Life Supports,Extracorporeal Membrane Oxygenations,Life Support, Extracorporeal,Membrane Oxygenation, Extracorporeal,Treatment, ECLS,Treatment, ECMO,Venoarterial ECMOs,Venovenous ECMOs

Related Publications

Tomoo Kishaba, and Tomoharu Suzuki, and Shoshin Yamazato, and Tadayoshi Miyagi, and Hiroaki Nagano
January 2021, Respirology case reports,
Tomoo Kishaba, and Tomoharu Suzuki, and Shoshin Yamazato, and Tadayoshi Miyagi, and Hiroaki Nagano
January 2020, Acute medicine & surgery,
Tomoo Kishaba, and Tomoharu Suzuki, and Shoshin Yamazato, and Tadayoshi Miyagi, and Hiroaki Nagano
January 2024, Journal of thoracic disease,
Tomoo Kishaba, and Tomoharu Suzuki, and Shoshin Yamazato, and Tadayoshi Miyagi, and Hiroaki Nagano
December 2020, Cureus,
Tomoo Kishaba, and Tomoharu Suzuki, and Shoshin Yamazato, and Tadayoshi Miyagi, and Hiroaki Nagano
March 2024, Perfusion,
Tomoo Kishaba, and Tomoharu Suzuki, and Shoshin Yamazato, and Tadayoshi Miyagi, and Hiroaki Nagano
May 2024, Medicina intensiva,
Tomoo Kishaba, and Tomoharu Suzuki, and Shoshin Yamazato, and Tadayoshi Miyagi, and Hiroaki Nagano
March 2018, Journal of thoracic disease,
Tomoo Kishaba, and Tomoharu Suzuki, and Shoshin Yamazato, and Tadayoshi Miyagi, and Hiroaki Nagano
October 2020, Journal of cardiac surgery,
Tomoo Kishaba, and Tomoharu Suzuki, and Shoshin Yamazato, and Tadayoshi Miyagi, and Hiroaki Nagano
January 2024, ASAIO journal (American Society for Artificial Internal Organs : 1992),
Tomoo Kishaba, and Tomoharu Suzuki, and Shoshin Yamazato, and Tadayoshi Miyagi, and Hiroaki Nagano
February 2021, Journal of critical care,
Copied contents to your clipboard!